Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,033 | 403 | 95.1% |
| Education | $411.91 | 27 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $2,002 | 113 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $883.61 | 35 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $698.36 | 46 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $654.38 | 39 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $579.17 | 33 | $0 (2024) |
| Amgen Inc. | $562.96 | 28 | $0 (2024) |
| Keryx Biopharmaceuticals, Inc. | $417.65 | 24 | $0 (2018) |
| Vifor Pharma, Inc. | $413.49 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $335.38 | 17 | $0 (2023) |
| AbbVie, Inc. | $301.69 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $931.08 | 42 | AstraZeneca Pharmaceuticals LP ($242.41) |
| 2023 | $1,110 | 55 | AstraZeneca Pharmaceuticals LP ($242.10) |
| 2022 | $1,264 | 64 | Fresenius USA Marketing, Inc. ($424.77) |
| 2021 | $1,243 | 77 | Fresenius USA Marketing, Inc. ($423.26) |
| 2020 | $415.26 | 23 | Otsuka America Pharmaceutical, Inc. ($81.94) |
| 2019 | $1,266 | 74 | Fresenius USA Marketing, Inc. ($360.56) |
| 2018 | $906.14 | 48 | Keryx Biopharmaceuticals, Inc. ($263.10) |
| 2017 | $1,310 | 47 | AbbVie, Inc. ($301.69) |
All Payment Transactions
430 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: NEPHROLOGY | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/31/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/29/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Nephrology | ||||||
| 10/28/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Nephrology | ||||||
| 10/07/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $16.72 | General |
| Category: NEPHROLOGY | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardio-renal | ||||||
| 09/23/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $18.48 | General |
| Category: NEPHROLOGY | ||||||
| 08/28/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $12.51 | General |
| Category: NEPHROLOGY | ||||||
| 08/21/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Nephrology | ||||||
| 07/30/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Nephrology | ||||||
| 07/17/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $11.87 | General |
| Category: NEPHROLOGY | ||||||
| 06/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $8.13 | General |
| Category: NEPHROLOGY | ||||||
| 06/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 05/23/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.52 | General |
| Category: NEPHROLOGY | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/21/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Nephrology | ||||||
| 05/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 04/18/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $21.93 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,142 | 4,211 | $636,968 | $235,382 |
| 2022 | 18 | 1,444 | 8,611 | $810,521 | $302,063 |
| 2021 | 19 | 1,445 | 9,600 | $837,296 | $326,318 |
| 2020 | 20 | 1,745 | 11,517 | $1.2M | $407,170 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 130 | 202 | $142,612 | $53,550 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 428 | $107,000 | $34,740 | 32.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 176 | 549 | $77,409 | $32,950 | 42.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 64 | 104 | $60,632 | $23,105 | 38.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 105 | 221 | $44,642 | $19,953 | 44.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 110 | 322 | $46,368 | $17,579 | 37.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 104 | 109 | $42,728 | $14,129 | 33.1% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 32 | 57 | $33,174 | $12,528 | 37.8% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Office | 2023 | 19 | 20 | $27,280 | $8,554 | 31.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $24,192 | $7,615 | 31.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 54 | $14,418 | $5,385 | 37.4% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 19 | 27 | $10,719 | $4,105 | 38.3% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 32 | 2,050 | $4,654 | $757.01 | 16.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 12 | 12 | $1,140 | $432.12 | 37.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 170 | 220 | $155,320 | $60,723 | 39.1% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Office | 2022 | 39 | 43 | $104,662 | $38,173 | 36.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 102 | 156 | $90,948 | $35,584 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 226 | 398 | $99,500 | $33,990 | 34.2% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Office | 2022 | 43 | 48 | $65,472 | $25,438 | 38.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 154 | 158 | $61,936 | $24,024 | 38.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 177 | 413 | $58,233 | $22,746 | 39.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 123 | 327 | $47,088 | $18,300 | 38.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 98 | 196 | $39,592 | $15,527 | 39.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 66 | 66 | $28,512 | $9,296 | 32.6% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 25 | 35 | $20,370 | $7,962 | 39.1% |
About Dr. Frederick Lee, M.D
Dr. Frederick Lee, M.D is a Internal Medicine healthcare provider based in Monroe, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962448266.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederick Lee, M.D has received a total of $8,445 in payments from pharmaceutical and medical device companies, with $931.08 received in 2024. These payments were reported across 430 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($8,033).
As a Medicare-enrolled provider, Lee has provided services to 5,776 Medicare beneficiaries, totaling 33,939 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Monroe, LA
- Active Since 06/22/2006
- Last Updated 12/02/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962448266
Products in Payments
- Velphoro (Drug) $2,002
- Auryxia (Drug) $811.11
- LOKELMA (Drug) $644.19
- Veltassa (Drug) $629.36
- Kerendia (Drug) $579.17
- RAYALDEE (Drug) $479.27
- JYNARQUE (Drug) $310.56
- FARXIGA (Drug) $239.42
- Parsabiv (Biological) $237.50
- AURYXIA (Drug) $234.15
- Parsabiv (Drug) $231.13
- Rayaldee (Drug) $219.09
- ENTRESTO (Drug) $215.82
- INJECTAFER (Drug) $206.53
- Viekira (Drug) $201.74
- ACTHAR (Biological) $135.20
- TARPEYO (Drug) $134.73
- TAVNEOS (Drug) $73.91
- BPV-Fluency (Device) $72.32
- Envarsus XR (SP) (Drug) $52.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Monroe
Nauman Khalid, Md, MD
Internal Medicine — Payments: $29,532
Dr. Manan Pandya, Do, DO
Internal Medicine — Payments: $15,227
Gurmeet Singh, Do, DO
Internal Medicine — Payments: $12,910
Dr. Gaurav Chand, D.o, D.O
Internal Medicine — Payments: $10,898
Bryan Kirkland, Md, MD
Internal Medicine — Payments: $9,716
Dr. Narendra Kutnikar, Md, MD
Internal Medicine — Payments: $8,960